Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial-Reference-Cited by-同舟云学术

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

Published:2011-03 Issue:9768 Volume:377 Page:837-847
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Budde Klemens,Becker Thomas,Arns Wolfgang,Sommerer Claudia,Reinke Petra,Eisenberger Ute,Kramer Stefan,Fischer Wolfgang,Gschaidmeier Harald,Pietruck Frank

Funder

Astellas Pharma

Novartis

Novartis Pharma

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Reduced exposure to calcineurin inhibitors in renal transplantation;Ekberg;N Engl J Med,2007

2. The natural history of chronic allograft nephropathy;Nankivell;N Engl J Med,2003

3. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology;Nankivell;Transplantation,2004

4. Calcineurin inhibitor-free immunosuppression in kidney transplantation;Guerra;Transpl Int,2007

5. Calcineurin inhibitor nephrotoxicity;Naesens;Clin J Am Soc Nephrol,2009

Cited by 318 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression in Kidney Transplant Recipients: An Update for the General Nephrologist;Advances in Kidney Disease and Health;2024-09

2. STABILITY INDICATING HIGH-PERFORMANCE THIN LAYER LIQUID CHROMATOGRAPHIC METHOD FOR EVEROLIMUS;International Journal of Pharmacy and Pharmaceutical Sciences;2024-09-01

3. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

4. Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients;Journal of Clinical Medicine;2024-07-23

5. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis;Transplantation Reviews;2024-07